Site-directed mutagenesis is one of the key methods used to study gene function.
定点突变是研究基因功能的一种关键方法。
Many research groups successfully rely on whole-gene random mutagenesis and recombination approaches for the directed evolution of enzymes.
许多研究小组利用整基因随机突变形成和重组方法，已成功的进行了酶的定向进化。
AIM: To establish the mutant of coding calcium binding fragment of the 13th exon of human thrombospondin-1 (TSP-1) gene with polymerase chain reaction (PCR) site directed mutagenesis technology.
目的：利用聚合酶链反应定点突变技术构建人血小板反应素1基因第13外显子编码钙结合域突变体。
To clarify the regulatory mechanism, site-directed mutagenesis and reporter gene assay in the CHO cell line were used.
为了阐明调控机制，我们采用了点突变实验和在CHO细胞系中的报告基因分析。
The mutant G138P was obtained by in vitro site directed mutagenesis of GI gene.
用双引物法对GI基因进行体外定点突变，构建了GI突变体g 138p。
The principles, operation and applications of site-directed mutagenesis, gene fusion technology, and post-translational modification methods were introduced emphatically.
着重阐述了基因定点突变技术、基因融合技术和翻译修饰技术等新兴定点固定化技术的原理、特点和操作。
Human brain derived neurotrophic factor gene was used as template for oligonucleotide based site directed mutagenesis and PCR.
应用寡核苷酸诱导的定点突变和PCR技术对人脑源性神经营养因子基因进行突变，并完成了测序鉴定。
Human brain derived neurotrophic factor gene was used as template for oligonucleotide based site directed mutagenesis and PCR.
应用寡核苷酸诱导的定点突变和PCR技术对人脑源性神经营养因子基因进行突变，并完成了测序鉴定。
应用推荐